About Us

Accelerating Brain Science & Neuro Drug Discovery with AI

Founded in 2020, Guangdong BayONE Life Sciences (BayONE Scientific) combines AI and laboratory animal technology — delivering proprietary intelligent instruments and data platforms for neuroscience research and drug discovery.

BayONE has raised tens of millions in financing, earned High-tech Enterprise and Technology SME certifications, participated in Guangdong key R&D programs, and achieved breakthroughs in AI-powered neurobehavioral analysis for brain disease models.

BayONE Life Sciences team
80+
Interdisciplinary Team

80+ members spanning computer science, life sciences, data analytics, and hardware/software engineering — advancing neurobehavioral innovation across disciplines.

50+
IP Assets

50+ software copyrights and patents spanning instrument control, neurobehavioral analysis, 3D capture, and data platforms — fully self-developed core technology.

200+
Labs Deployed

Deployed in 200+ research labs worldwide, serving neuroscience and drug discovery institutions.

50+
Customer Publications

Customers have published 50+ papers in domestic and international journals using BayONE products — validating our technology and research impact.

Our Values

Guided by AI FOR SCIENCE — connecting intelligent instruments, animal models, and data platforms for global neuroscience and CNS drug R&D.

Vision

Build an AI-driven acceleration platform for brain science and neuro drug discovery.

Mission

Accelerate brain science and CNS drug R&D with AI and full-spectrum phenomics.

Philosophy

AI FOR SCIENCE — using artificial intelligence to upgrade paradigms and leapfrog efficiency in life-science research.

Positioning

Integrating AI, computer vision, and neuroscience to build next-generation life-science instruments and data platforms — serving global brain science, neuropsychiatric research, and biopharma as an AI-driven industry leader.

Our Locations

Guangzhou HQ · Shenzhen animal center · Jiaxing manufacturing — full R&D, services, and production chain.

Guangzhou HQ

Guangdong BayONE Life Sciences Co., Ltd.

R&D · Operations · Sales

Integrating AI, computer vision, and neuroscience to build next-generation life-science instruments and data platforms — serving global brain science, neuropsychiatric research, and biopharma as an AI-driven industry leader.

Shenzhen Subsidiary

Shenzhen BayONE Biotech Co., Ltd.

Animal Center

2,100 m² SPF barrier facility with 10,000 mouse/rat cages — an integrated CRO platform for breeding, disease model development, and experimental services in brain science and brain-inspired intelligence research.

Jiashan Subsidiary

BayONE Life Sciences (Jiaxing) Co., Ltd.

Manufacturing

Leveraging the Yangtze River Delta biopharma cluster, smart manufacturing ecosystem, and research talent — building Jiashan as our R&D and production hub for intelligent instruments.

Our Journey

Key milestones from core technology breakthroughs to commercialization, funding, and global academic presence.

2026

User papers · outreach · global partnership

  • 50th user publication milestone
  • Selected as an MIIT typical AI application case
  • Core product named Guangdong Famous High-Tech Product
  • Named Huangpu District Outstanding Science Outreach Unit
  • Hosted GBA multi-species brain disease models & intelligent behavior phenotyping symposium
  • Strategic partnership with Pfizer
  • Fully automated eight-paradigm fine motor behavior assessment system coming soon
  • HCM smart home-cage system coming soon
2025

Guangzhou Bio Island · cloud · LLM agent

  • HQ relocated to Guangzhou Bio Island
  • Jiaxing subsidiary completed
  • Shenzhen's only dual-licensed (production/use) animal facility
  • EthoAI research cloud launched
  • EthoAgent LLM agent launched
2024

Series A · 100 instruments · global debut

  • Raised tens of millions in Series A
  • 100th AI fine-behavior instrument deployed
  • Social behavior AI algorithm published in Nature family journal
  • Debut at European and US neuroscience conferences
2023

National high-tech & first user publication

  • Certified as National High-tech Enterprise
  • First user research paper on postoperative delirium in mice published
2022

Patents & animal facility license

  • Granted 3 national invention patents
  • Granted Guangdong laboratory animal use license
2021

Nature subjournal publication & productization

  • Core BehaviorAtlas 3D-AI behavior analysis published in a Nature family journal
  • Product R&D officially launched
  • First user experiment completed at ShanghaiTech
2020

Shenzhen BayONE Life Sciences founded

  • Official founding — beginning the fusion of AI and laboratory animal technology

Our Team

Top researchers and engineers working across disciplines to advance AI-driven neurobehavioral innovation.

  • Top Talent Background: Elite talent from CAS, Sun Yat-sen University, Tongji University, Wageningen University, and other leading institutions.
  • Interdisciplinary Team: 75 members spanning computer science, life sciences, data analytics, and hardware/software engineering — building a comprehensive moat.
  • PhD Talent Density: Five PhDs deeply engaged in core technology R&D.
  • Research Excellence: Core technology published in a Nature family journal — internationally leading.
  • Open Culture: Candid communication and a highly collaborative R&D environment.

Our partners

Featured partners that help us scale

Client Map

Serving leading universities, research institutes, and biopharma companies across China and worldwide — building an AI-driven neurobehavioral research ecosystem.

Universities & Institutes (partial) Enterprises & Hospitals (partial) International Partners

Loading map…

Partner with Us to Accelerate Neuro Drug Discovery

Contact us for research instruments, CRO services, and EthoAI cloud collaboration.